Упрощенная HTML-версия
138
129.
Goswami V.J. Dilated cardiomyopathy [Электронныйресурс] / Goswami
V.J., Wilklow F.E., Celebi M.M. – 2010. – Режимдоступа:
130.
Granger C. B. Prediction and prevention of chemotherapy-induced cardio-
myopathy can it be done? / C. B. Granger // Circulation. – 2006. – Vol.
114. – P. 2432-2433.
131.
Guidelines for the ultrasound assessment of endothelial-dependent flow-
mediated vasodilation of the brachial artery: a report of the International
Brachial Artery Reactivity Task Force / M. C. Corretti [et al.] // J. Am.
Coll. Cardiol. – 2002. –Vol. 39. –P. 257-265.
132.
Inverse association between serum total cholesterol and cancer mortality in
Dutch civil servants / A. J. Schuit [et al.] // Am. J. Epidemiol. – 1993. –
Vol. 137. – P. 966-976.
133.
Khakoo A. Y. Management of CV Disease in Patient with Cancer / A. Y.
Khakoo, E. T. H. Yoh // Nat. Clin. Pract. Oncol. – 2008. – Vol. 5, № 11. –
P. 655-667.
134.
Khorana A. A. Cancer and thrombosis: implications of published guide-
lines for clinical practice / A. A. Khorana // Ann. Oncol. – 2009. – Vol. 20,
№ 10. – P. 1619-1630.
135.
Kones R. The Jupiter study, CRP screening, and aggressive statin therapy –
implications for the primary prevention of cardiovascular disease / R.
Kones // Ther. Adv. Cardiovasc. Dis. – 2009. – Vol. 3, № 4. – P. 309-315.
136.
Koyuturk M. Simvastatin induces proliferation inhibition and apoptosis in
C6 glioma cells via c-jun N-terminal kinase / M. Koyuturk, M. Ersoz, N.
Altiok // Neurosci. Lett. – 2004. – Vol. 370. – P. 212-217.
137.
Kristeleit R. Cardiotoxicity from cytotoxics in the 21-st century / R. Kris-
teleit, M. O. Brien // Br. J. Cardiol. – 2009. – Vol.16, № 2. – Р. 60-62.
138.
Lenihan D.J. Early detection of cardiotoxicity during chemotherapy using
biomarkers / D.J. Lenihan [et al.]// JCardFail.-2007.-vol. 13.- P.151.